Moreover, in human breast cancer cells, RNAi-mediated silencing of TIMP1 induced cell cycle arrest at the G1 phase associated with AKT and NFκB signaling pathway inhibition [20]. This evidence concerns the gene TIMP1 and breast carcinoma.